https://genomethods.org/signal/vanderbilt-team-unlocks-molecular-secrets-in-decades-old-human-tissue-96910/2026-09-22T15:39:00-07:00https://genomethods.org/signal/single-crispr-infusion-cuts-stubborn-ldl-cholesterol-for-a-year-96909/2026-09-22T13:42:00-07:00https://genomethods.org/signal/precure-llc-and-helix-launch-million-sample-multiomics-push-at-mayo-clinic-96908/2026-09-22T11:46:00-07:00https://genomethods.org/signal/regulatory-hurdles-put-city-of-hope-s-panxeon-pancreatic-cancer-test-to-the-test-96868/2026-09-22T10:59:00-07:00https://genomethods.org/signal/genomic-mapping-unlocks-new-insights-into-threatened-asian-hornbills-96824/2026-09-22T09:34:00-07:00https://genomethods.org/signal/phase-iii-trial-data-volumes-double-every-seven-years-as-complexity-becomes-the-new-normal-96752/2026-09-22T08:22:00-07:00https://genomethods.org/signal/australian-government-funds-international-car-t-clinical-trials-for-children-96753/2026-09-22T06:45:00-07:00https://genomethods.org/signal/uzbekistan-plans-biome-center-for-cell-technologies-and-genomics-96737/2026-09-21T23:37:00-07:00https://genomethods.org/signal/sidra-medicine-develops-genomic-tool-to-predict-risk-of-cognitive-decline-96738/2026-09-21T22:32:00-07:00https://genomethods.org/signal/gene-editing-strategies-take-center-stage-in-malaria-research-at-mdu-96739/2026-09-21T20:25:00-07:00https://genomethods.org/signal/ai-designed-genome-editors-offer-new-options-for-rice-gene-editing-96740/2026-09-21T19:22:00-07:00https://genomethods.org/signal/briacell-therapeutics-advances-off-the-shelf-cancer-immunotherapy-into-late-stage-clinical-trials-96754/2026-09-21T18:26:00-07:00https://genomethods.org/signal/cardinal-health-targets-double-digit-earnings-growth-as-specialty-business-expands-96771/2026-09-21T16:01:00-07:00https://genomethods.org/signal/ai-patient-profiling-challenges-the-meaning-of-failed-clinical-trials-96756/2026-09-21T14:20:00-07:00https://genomethods.org/signal/abbvie-pursues-dual-antibody-strategy-to-reshape-lung-cancer-treatment-96757/2026-09-21T13:16:00-07:00https://genomethods.org/signal/ireland-s-cell-therapy-sector-depends-on-imports-as-demand-for-activation-beads-rises-96758/2026-09-21T12:11:00-07:00https://genomethods.org/signal/uk-and-israel-pursue-new-science-and-tech-partnerships-despite-political-tensions-96741/2026-09-21T09:23:00-07:00https://genomethods.org/signal/car-t-therapy-transforms-relapsed-lymphoma-into-a-race-for-treatment-access-96760/2026-09-21T07:52:00-07:00https://genomethods.org/signal/gujarat-themis-biosyn-completes-rs-1-200-crore-acquisition-of-microbiopharm-japan-96772/2026-09-21T05:41:00-07:00https://genomethods.org/signal/latus-bio-brings-on-new-board-leaders-as-gene-therapy-trials-approach-96773/2026-09-21T04:25:00-07:00https://genomethods.org/signal/lokahi-therapeutics-extends-partnership-with-university-of-alabama-for-hands-on-biotech-asset-scouting-96774/2026-09-21T04:24:00-07:00https://genomethods.org/signal/ai-designs-new-viruses-to-fight-bacteria-and-rewrites-the-rules-of-biotechnology-96743/2026-09-21T04:23:00-07:00https://genomethods.org/signal/bristol-myers-squibb-s-arlo-cel-meets-phase-ii-goal-in-relapsed-multiple-myeloma-96761/2026-09-21T04:21:00-07:00https://genomethods.org/signal/gene-edited-rice-faces-backlash-as-coalition-demands-urgent-policy-reversal-in-india-96745/2026-09-21T04:21:00-07:00https://genomethods.org/signal/early-decisions-in-cell-and-gene-therapy-shape-patient-access-for-years-96762/2026-09-21T04:20:00-07:00https://genomethods.org/signal/genomics-driven-translocation-sparks-early-breeding-surge-in-florida-scrub-jays-96746/2026-09-21T04:19:00-07:00https://genomethods.org/signal/bristol-myers-squibb-ends-development-of-orum-therapeutics-orm-6151-after-early-trial-review-96763/2026-09-21T04:16:00-07:00https://genomethods.org/signal/andrew-dauber-honored-for-advances-in-pediatric-endocrinology-research-96747/2026-09-21T04:14:00-07:00https://genomethods.org/signal/ai-agents-push-into-science-as-safety-concerns-and-funding-surge-96748/2026-09-21T04:13:00-07:00https://genomethods.org/signal/biocytics-partners-with-eremid-for-single-cell-sequencing-in-cancer-cell-therapy-96749/2026-09-21T04:12:00-07:00https://genomethods.org/signal/stanford-deploys-37-000-ai-agents-to-speed-up-drug-discovery-96764/2026-09-21T04:11:00-07:00https://genomethods.org/signal/car-t-therapy-brings-remission-for-scottish-myeloma-patient-after-standard-treatments-fail-96765/2026-09-21T04:10:00-07:00https://genomethods.org/signal/holtec-nuclear-delays-ipo-as-nscale-eyes-multibillion-dollar-debut-96775/2026-09-21T04:09:00-07:00https://genomethods.org/signal/car-t-clinical-trial-pipeline-accelerates-as-over-180-companies-advance-next-generation-therapies-96766/2026-09-21T04:07:00-07:00https://genomethods.org/signal/mayo-clinic-scientists-find-new-way-to-expose-hidden-thyroid-tumors-to-car-t-therapy-96767/2026-09-21T04:05:00-07:00https://genomethods.org/signal/bristol-myers-squibb-ends-orum-therapeutics-aml-drug-after-phase-i-review-96777/2026-09-21T04:04:00-07:00https://genomethods.org/signal/single-car-t-injection-prompts-immune-reset-in-multiple-sclerosis-trial-96768/2026-09-21T04:04:00-07:00https://genomethods.org/signal/lsua-secures-landmark-accreditation-for-accelerated-bioinformatics-and-it-degrees-96750/2026-09-21T04:02:00-07:00https://genomethods.org/signal/roche-signs-1b-discovery-deal-for-dualitas-bispecific-antibody-platform-96779/2026-09-21T04:02:00-07:00https://genomethods.org/signal/arovella-therapeutics-gets-fda-clearance-to-start-first-human-trial-of-ala-101-cell-therapy-96769/2026-09-21T04:00:00-07:00https://genomethods.org/signal/certara-tackles-clinical-data-headaches-with-early-standards-checks-96770/2026-09-21T03:54:00-07:00https://genomethods.org/signal/sk-biopharmaceuticals-acquires-global-rights-to-preclinical-parkinson-s-drug-in-deal-with-1st-biotherapeutics-96780/2026-09-21T03:49:00-07:00https://genomethods.org/signal/north-carolina-biotech-bets-on-proof-before-scale-in-a-fragmented-funding-surge-96776/2026-09-21T04:07:00-07:00https://genomethods.org/signal/gene-edited-rootstock-offers-hope-for-florida-citrus-survival-96751/2026-09-21T03:48:00-07:00